VLP Therapeutics
PrivateLast Round
Grant
Dec 11, 2025
Total Funding Raised
$41.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VLP Therapeutics is a biotechnology company that develops next-generation vaccine technologies to treat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VLP Therapeutics Comparables
Compare VLP Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TechnoVax, Inc. | 86% | |
| VLP Biotech, Inc. | 86% | |
| SpyBiotech | 84% | |
VLP Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2025 | ||||
| Grant | Mar 17, 2025 | ||||
| VC Round | Nov 8, 2023 | ||||
| Grant | Oct 3, 2022 | ||||
| Series A Extension | Dec 27, 2021 | ||||
Series A | Mar 15, 2021 |
VLP Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| National Cancer Institute | Grant |
| Phoenixi Co., Ltd. | VC Round |
| Sumitomo Mitsui Trust Bank | VC Round |
| United States Department of Defense | Grant |
| MUFG Bank | VC Round, Series A Extension |
| 株式会社FFGベンチャービジネスパートナーズ | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 74% MoM.
- May 3, 2025
Monthly visitors grew 66% MoM, reaching 1.4K.
VLP Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VLP Therapeutics's valuation, stock price, and market status.